Research & Development World

  • Home Page
  • Topics
    • Aerospace
    • Archeology
    • Automotive
    • Biotech
    • Chemistry
    • COVID-19
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Market Pulse
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
      • Software
    • Semiconductors
  • 2021 R&D 100 Award Winners
    • R&D 100 Awards
    • 2020 Winners
    • Winner Archive
  • Resources
    • Digital Issues
    • Podcasts
    • Subscribe
  • Global Funding Forecast
  • Webinars

Data Analysis Software

By R&D Editors | December 8, 2010

Qlucore, a world leader in the development of bioinformatics software, has unveiled Qlucore Omics Explorer 2.2, the latest version of its advanced data analysis software, which now features new built-in functionality to import and normalise miRNA data, mRNA data and DNA methylated data.

Qlucore Omics Explorer 2.2 (OE 2.2) also now allows for the direct import of data generated with Agilent equipment. Data generated with the Agilent Feature Extraction software can now be directly imported into Qlucore Omics Explorer 2.2, so that scientists, biologists and other researchers benefit from a more streamlined workflow. The import functionality included with Qlucore Omics Explorer 2.2 also features inbuilt pre-settings for well-defined data types, as well as a flexible interface for the normalisation of other data types.

For the first time, Qlucore Omics Explorer 2.2 is now also available in a 64 bit version for researchers using a 64 bit operating system. Benefits of this version include higher performance, as well as the ability to utilise additional RAM memory. As such, Qlucore Omics Explorer 2.2 can now be used to work with datasets containing up to 150 samples and 2 million variables, using just a regular computer.

“Qlucore Omics Explorer 2.2 now makes it very easy to import data generated with both Agilent and Affymetrix, which means that the entire data analysis process can be handled much more efficiently,” says Carl-Johan Ivarsson, President, Qlucore. “Qlucore Omics Explorer has always been a very powerful tool for conducting advanced data analysis. However, the latest enhancements that we’ve included in Qlucore Omics Explorer 2.2 will make it even easier for researchers, biologists and scientists to import and analyse their own data, as well as data produced by their peers, both quickly and easily.”

Because Qlucore Omics Explorer 2.2 supports instant data analysis, this latest version of the software will enable scientists and biologists to explore different hypotheses and alternative scenarios within seconds. The software will therefore be invaluable for unveiling important new discoveries, as it will allow the actual researchers – the people with the most biological insight – to study the data and to look for patterns and structures, without needing to be a statistics or computer expert.

Qlucore

Related Articles Read More >

New dangers in the woods — and the hope that research offers us
PerkinElmer participating at Bio-IT World Conference & Expo
Nalu Medical’s mIPG is focus of Episode 7 of R&D 100 – The Podcast
R&D 100 winner of the day: Portable EnGineered Analytic Sensor with aUtomated Sampling (PEGASUS)
2021 R&D Global Funding Forecast

Need R&D World news in a minute?

We Deliver!
R&D World Enewsletters get you caught up on all the mission critical news you need in research and development. Sign up today.
Enews Signup

R&D World Digital Issues

February 2020 issue

Browse the most current issue of R&D World and back issues in an easy to use high quality format. Clip, share and download with the leading R& magazine today.

Research & Development World
  • Subscribe to R&D World Magazine
  • Enews Sign Up
  • Contact Us
  • About Us
  • Drug Discovery & Development
  • Pharmaceutical Processing
  • 2022 Global Funding Forecast

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search R&D World

  • Home Page
  • Topics
    • Aerospace
    • Archeology
    • Automotive
    • Biotech
    • Chemistry
    • COVID-19
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Market Pulse
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
      • Software
    • Semiconductors
  • 2021 R&D 100 Award Winners
    • R&D 100 Awards
    • 2020 Winners
    • Winner Archive
  • Resources
    • Digital Issues
    • Podcasts
    • Subscribe
  • Global Funding Forecast
  • Webinars